drug protocol number

61186372NSC2012

drug sponsor

Janssen Pharmaceutica NV / IQIVIA

drug study

Lasertinib

drug trial site

King Khalid University Hospital (Riyadh), King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase